FI891012A - Menetelmä ja väline immuunikokeissa esiintyvien häiriötekijöiden kompensoimiseksi - Google Patents

Menetelmä ja väline immuunikokeissa esiintyvien häiriötekijöiden kompensoimiseksi Download PDF

Info

Publication number
FI891012A
FI891012A FI891012A FI891012A FI891012A FI 891012 A FI891012 A FI 891012A FI 891012 A FI891012 A FI 891012A FI 891012 A FI891012 A FI 891012A FI 891012 A FI891012 A FI 891012A
Authority
FI
Finland
Prior art keywords
immunoassays
compensating
instrument
interfering factors
substance
Prior art date
Application number
FI891012A
Other languages
English (en)
Swedish (sv)
Other versions
FI891012A0 (fi
FI92879C (fi
FI92879B (fi
Inventor
Helmut Lenz
Ellen Moessner
Werner Stock
Norbert Franken
Robert Crane Mccarthy
Albert Roeder
Harald Haug
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of FI891012A0 publication Critical patent/FI891012A0/fi
Publication of FI891012A publication Critical patent/FI891012A/fi
Application granted granted Critical
Publication of FI92879B publication Critical patent/FI92879B/fi
Publication of FI92879C publication Critical patent/FI92879C/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/824—Immunological separation techniques
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Electrotherapy Devices (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Steroid Compounds (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Automatic Analysis And Handling Materials Therefor (AREA)
FI891012A 1988-03-03 1989-03-02 Menetelmä ja väline immuunikokeissa esiintyvien häiriötekijöiden kompensoimiseksi FI92879C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16405488 1988-03-03
US07/164,054 US4914040A (en) 1988-03-03 1988-03-03 Reagent and method for determination of a polyvalent substance using an immunoaggregate

Publications (4)

Publication Number Publication Date
FI891012A0 FI891012A0 (fi) 1989-03-02
FI891012A true FI891012A (fi) 1989-09-04
FI92879B FI92879B (fi) 1994-09-30
FI92879C FI92879C (fi) 1995-01-10

Family

ID=22592781

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891012A FI92879C (fi) 1988-03-03 1989-03-02 Menetelmä ja väline immuunikokeissa esiintyvien häiriötekijöiden kompensoimiseksi

Country Status (18)

Country Link
US (1) US4914040A (fi)
EP (1) EP0331068B1 (fi)
JP (1) JPH0823560B2 (fi)
AT (1) ATE82072T1 (fi)
AU (1) AU616484B2 (fi)
CA (1) CA1340572C (fi)
DD (1) DD280396A5 (fi)
DE (2) DE3905505A1 (fi)
DK (1) DK175429B1 (fi)
ES (1) ES2045216T3 (fi)
FI (1) FI92879C (fi)
GR (1) GR3006991T3 (fi)
HU (1) HU212322B (fi)
IE (1) IE62974B1 (fi)
LV (1) LV10538B (fi)
PT (1) PT89889B (fi)
RU (1) RU2032906C1 (fi)
ZA (1) ZA891568B (fi)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3730059A1 (de) * 1987-09-08 1989-03-30 Behringwerke Ag Verfahren zur bestimmung von "loeslichem" fibrin
US5141853A (en) * 1988-07-22 1992-08-25 Abbott Laboratories Determination of ammonia levels in a sample
DE3829245A1 (de) * 1988-08-29 1990-03-01 Boehringer Mannheim Gmbh Verfahren zur bestimmung einer spezifisch bindefaehigen substanz
AU6710790A (en) * 1989-10-24 1991-05-31 E.I. Du Pont De Nemours And Company Use of polymerized immunoglobulin to reduce the incidence of false-positive responses in immunoassays
DE4020204A1 (de) * 1990-06-25 1992-01-02 Boehringer Mannheim Gmbh Durchfuehrung eines homogenen immunoassays nach dem agglutinationsprinzip
US6274325B1 (en) 1990-06-25 2001-08-14 Boehringer Mannheim Gmbh Method for carrying out a homogeneous-immunoassay based on agglutination
JPH04350559A (ja) * 1991-05-28 1992-12-04 Dai Ichi Pure Chem Co Ltd 特異抗体の測定法
WO1993003366A1 (en) * 1991-07-26 1993-02-18 E.I. Du Pont De Nemours And Company Method for eliminating erroneous results in an immunoassay
US5460944A (en) * 1991-10-28 1995-10-24 Boehringer Mannheim Gmbh Storable protein solution
DE4202923A1 (de) * 1992-02-01 1993-08-05 Behringwerke Ag Verfahren zur bestimmung von antigenen oder antikoerpern in gegenwart eines immunkomplexes
IL102495A (en) * 1992-07-14 1998-06-15 Patchornik Avraham Universal standard reagents, method of preparing same and use thereof
IL106887A (en) * 1993-09-02 1997-02-18 Yissum Res Dev Co Pharmaceutical and diagnostic compositions and a method for drug targeting
GB9403215D0 (en) * 1994-02-19 1994-04-13 Kodak Ltd Chemical modification of antibodies and antigens
WO1995023801A1 (de) * 1994-03-05 1995-09-08 Boehringer Mannheim Gmbh Entstörmittel zum einsatz bei immunoassays
DE4407423A1 (de) * 1994-03-05 1995-09-07 Boehringer Mannheim Gmbh Entstörmittel zum Einsatz bei Immunoassays
DE4439452A1 (de) * 1994-11-04 1996-05-09 Boehringer Mannheim Gmbh Antikörperklassenspezifisches Entstörungsreagenz
DE19621133A1 (de) * 1996-05-24 1997-11-27 Boehringer Mannheim Gmbh Bestimmungsverfahren mit oligomerisierten Rezeptoren
DE19731465A1 (de) * 1997-07-22 1999-01-28 Boehringer Mannheim Gmbh Verwendung von Kontrollflächen zur Detektion von Störproben in einem Nachweisverfahren
ES2185104T3 (es) * 1997-12-11 2003-04-16 Roche Diagnostics Gmbh Eliminacionde las interferencias en procedimientos de diagnostico mediante peptidos de d-aminoacidos.
DE19828466A1 (de) * 1998-06-26 1999-12-30 Roche Diagnostics Gmbh Entstörung von Immunoassays durch Substanzen, die aus den Framework-Regionen von Antikörpern abgeleitet sind
US6406858B1 (en) * 1998-11-27 2002-06-18 Bayer Corporation System for the reduction of interferences in immunoassays
CA2422856C (en) * 2000-09-25 2012-02-07 Abbott Laboratories Methods and kits for decreasing interferences of assay samples containing plasma or serum in specific binding assays by using a large polycation
DE10059720A1 (de) 2000-11-30 2002-06-06 Roche Diagnostics Gmbh Verwendung intramolekular kovalent vernetzter Proteine als Bindepartner in Immunoassays
DE10064827A1 (de) 2000-12-22 2002-06-27 Dade Behring Marburg Gmbh Nachweisverfahren
US20040091952A1 (en) * 2002-07-25 2004-05-13 Sysmex Corporation Reagent kit for detecting lupus anticoagulant
US20040018556A1 (en) * 2002-07-29 2004-01-29 Cantor Thomas L. Reagent and method for determination of a substance using an immunoaggregator
EP1469317B1 (en) * 2003-03-28 2008-10-08 Sysmex Corporation Reagent for detecting anti-phospholipid antibody
JP2007526993A (ja) * 2003-07-08 2007-09-20 インバーネス・メデイカル・スウイツツアーランド・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング 粒子凝集検出方法および装置
US20050112586A1 (en) * 2003-11-24 2005-05-26 Roland Janzen Method and composition for stabilizing liquid reagents
DE602005006633D1 (de) * 2004-02-06 2008-06-26 Sysmex Corp Reagenziensatz zum Nachweis von Lupus-Antikoagulant.
CN1969189B (zh) * 2004-06-14 2012-03-21 协和梅迪克斯株式会社 非特异性反应被抑制的可溶性白介素-2受体免疫学测定方法和试剂
US20060105402A1 (en) * 2004-11-15 2006-05-18 Gennady Rott Blood type method system and device
US7172906B2 (en) * 2004-11-16 2007-02-06 Dade Behring Inc. Reduction of non-specific binding in assays
US20110189704A1 (en) * 2007-08-23 2011-08-04 Mitsubishi Chemical Medience Corporation Non-specific reaction inhibitor
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
WO2019207115A1 (en) * 2018-04-26 2019-10-31 Statens Serum Institut Improved immunoassays
CN109342743B (zh) * 2018-12-05 2022-02-18 菲鹏生物股份有限公司 一种能够与类风湿因子高效结合的变性IgG的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0083869B1 (en) * 1982-01-05 1985-10-16 International Institute Of Cellular And Molecular Pathology (Icp) Method of immunoassay
DE3206729A1 (de) * 1982-02-25 1983-09-01 Behringwerke Ag, 3550 Marburg Immunologisches agglutinationsverfahren
DE3225027A1 (de) * 1982-07-05 1984-01-05 Boehringer Mannheim Gmbh, 6800 Mannheim Immunchemisches messverfahren
US4659678A (en) * 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
US4474892A (en) * 1983-02-16 1984-10-02 Board Of Trustees Of The Leland Stanford Junior University Two-site immunoassays using monoclonal antibodies of different classes or subclasses and test kits for performing same
US4582810A (en) * 1983-09-30 1986-04-15 Becton, Dickinson And Company Immuno-agglutination particle suspensions
JPS60256057A (ja) * 1984-06-01 1985-12-17 Dai Ichi Pure Chem Co Ltd 免疫学的測定法
JPS6165162A (ja) * 1984-09-05 1986-04-03 Chemo Sero Therapeut Res Inst モノクロ−ナル抗体を用いた免疫学的測定方法における非特異反応吸収剤
JPH0799372B2 (ja) * 1985-07-13 1995-10-25 富士レビオ株式会社 逆受身凝集反応用非特異反応吸収剤

Also Published As

Publication number Publication date
DE3905505A1 (de) 1989-09-14
ES2045216T3 (es) 1994-01-16
AU3090889A (en) 1989-09-07
DE58902586D1 (de) 1992-12-10
US4914040A (en) 1990-04-03
PT89889A (pt) 1989-11-10
FI891012A0 (fi) 1989-03-02
JPH01254869A (ja) 1989-10-11
FI92879C (fi) 1995-01-10
LV10538B (en) 1995-12-20
HUT50988A (en) 1990-03-28
IE890683L (en) 1989-09-03
EP0331068B1 (de) 1992-11-04
ZA891568B (en) 1989-11-29
PT89889B (pt) 1994-05-31
RU2032906C1 (ru) 1995-04-10
GR3006991T3 (fi) 1993-06-30
DK175429B1 (da) 2004-10-18
IE62974B1 (en) 1995-03-08
ATE82072T1 (de) 1992-11-15
DK96689A (da) 1989-09-04
AU616484B2 (en) 1991-10-31
HU212322B (en) 1996-05-28
FI92879B (fi) 1994-09-30
DD280396A5 (de) 1990-07-04
CA1340572C (en) 1999-06-01
JPH0823560B2 (ja) 1996-03-06
DK96689D0 (da) 1989-02-28
EP0331068A1 (de) 1989-09-06
LV10538A (lv) 1995-02-20

Similar Documents

Publication Publication Date Title
FI891012A (fi) Menetelmä ja väline immuunikokeissa esiintyvien häiriötekijöiden kompensoimiseksi
ES2058212T3 (es) Inmunoensayo de aglutinacion de latex en presencia de hemoglobina.
NO903124D0 (no) Testmetode og reagenssett for denne.
GR860833B (en) Improvements in and relating to the determination of glycated hemoglobin in blood
NZ237535A (en) Carrier for binding anti-phospholipid antibodies, its use in immunoassays and kits and blood protein which enhances binding ability of antiphospholipid antibody
ATE74662T1 (de) Immunoanalysetestverfahren fuer cholesterolepoxide.
ES2148144T3 (es) Procedimiento para la estabilizacion de conjugados de enzima.
KR890702039A (ko) 1,25-디하이드록시 비타민 d의 분석 방법
ES8503855A1 (es) Procedimiento de inmunoanalisis homogeneo para determinar un analito en una muestra de ensayo.
ATE67599T1 (de) Heterogenes immunoassay.
EP0274198A3 (en) Immuno assays
ES555425A0 (es) Un metodo de medida de la concentracion de un ligando libre en un fluido biologico
DE3686717D1 (de) Immuntestverfahren.
NO884131L (no) Agglutineringsreagens og dets anvendelse for detektering av et antigen, antistoffer eller andre analytter.
ES2076221T3 (es) Derivados geminales de difenilo y su uso en inmunoensayos.
KR870001470A (ko) 인체 인터로이킨-2의 측정방법 및 측정시약
DE3863270D1 (de) Immuntest.
GB2011070A (en) Assay of vitamin B12
ES8405155A1 (es) Procedimiento de inmunoanalisis para determinar etosuximida en una muestra de analisis.
IT1227150B (it) Metodo per la determinazione della frazione libera di sostanze presenti nei fluidi biologici.

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: BOEHRINGER MANNHEIM GMBH

MA Patent expired